Summary
The effect of intracerebroventricular administration of histamine on the activity of mesolimbic and nigrostriatal dopaminergic (DA) neurons was determined in male rats. The activity of these neurons was estimated by measuring: (1) the accumulation of 3,4-dihydroxyphenylalanine (DOPA) after administration of a decarboxylase inhibitor, and (2) the concentration of 3,4-dihydroxyphenylacetic acid (DOPAC) in the nucleus accumbens and striatum, which contain the terminals of these neurons. Central administration of histamine increased both DOPA accumulation and DOPAC concentrations in the nucleus accumbens, but was without effect in the striatum. The increase in DOPAC concentrations in the nucleus accumbens occurred within 10 min and was sustained for at least 120 min. The H1 antagonist mepyramine blocked whereas the H2 antagonist zolantidine did not affect histamine-induced increases in DOPAC concentrations in the nucleus accumbens. Neither mepyramine nor zolantidine affected basal DOPAC concentrations in the nucleus accumbens. These results indicate that central administration of histamine stimulates mesolimbic DA neurons through an action at the H1 receptor, but has no effect upon the activity of nigrostriatal DA neurons.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barton AC, Moore KE, Demarest KT (1987) Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons. J Neural Transm 68:25–39
Bristow LJ, Bennett GW (1988 a) Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors. Br J Pharmacol 95:1292–1302
Bristow LJ, Bennett GW (1988 b) Behavioral and biochemical evidence for TRH modulation of histamine H1 receptor function in rat brain. Br J Pharmacol 95:886P
Bristow LJ, Bennett GW (1989) Effect of chronic intra-accumbens administration of the TRH analogue CG3509 on histamine-induced behaviour in the rat. Br J Pharmacol 97:745–752
Calcutt CR, Ganellin CR, Griffiths R, Leigh BK, Maguire JP, Mitchell RC, Mylek ME, Parsons ME, Smith IR, Young RC (1988) Zolantidine (SK & F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist. Br J Pharmacol 93:69–78
Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch Pharmacol 275:153–168
Chapin DS, Lookingland KE, Moore KE (1986) Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites. Curr Separations 7:68–70
Chronister RB, Palmer GC, Defrance JF, Sikes RW, Hubbard JI (1982) Histamine: correlative studies in the nucleus accumbens. J Neurobiol 13:23–37
Elliot PJ, Paris JM, Mitsushio H, Lorens SA (1990) Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration. Pharmacol Biochem Behav 37:329–333
Garrison JC (1990) Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists. In: Goodman AG, Wall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 575–599
Haley TJ (1983) Physiclal and biological properties of pyrilamine. J Pharm Sci 72:3–12
Hagan RM, Jones BJ, Jordan CC, Tyers MB (1990) Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. Br J Pharmacol 99:227–232
Heal DJ, Green AR (1979) Administration of thyrotropin releasing hormone (TRH) to rats releases dopamine in the n. accumbens but not n. caudatus. Neuropharmacology 18:23–31
Hough LB (1988) Cellular localization and possible functions for brain histamine: recent progress. Prog Neurobiol 30:469–505
Hough LB, Jackowski S, Eberle N, Gogas KR, Camarota NA, Cue D (1988) Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain. Biochem Pharm 37:4707–4711
Itowi N, Yamatodani A (1991) Comprehensive list of effects of centrally administered histamine and related compounds. In: Watanabe T, Wada H (eds) Histaminergic neurons: morphology and function. CRC Press, Boca Raton, pp 383–402
Kalivas PW (1982) Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J Pharmacol Exp Ther 222:37–42
Kalivas PW, Widerlöv E, Stanley D, Breese G, Prange AJ (1983) Enkephalin action on the mesolimbic system: A dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 227:229–237
Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522
Kelly PH, Iversen SD (1976) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45–56
König JFR, Klippel RA (1963) The rat brain: A stereotaxic atlas of forebrain and lower parts of the brainsteam. Krieger, Huntington
Lookingland KE, Moore KE (1984) Dopamine receptor mediated regulation of incertohypothalamic dopaminergic neurons in the male rat. Brain res 304:324–338
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the Folin-phenol reagent. J Biol Chem 193:265–275
Miyamoto M, Nagawa Y (1977) Mesolimbic involvement in the locomotor stimulant action of thyrotropin releasing hormone (TRH) in rats. Eur J Pharmacol 44:143–152
Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14:69–97
Moore KE (1987) Hypothalamic dopaminergic neuronal systems. In: Meltzer HY (ed) Psychopharmacology: The third generation of progress. Raven Press, New York, pp 127–139
Palkovits M (1973) Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 59:449–450
Pijnenburg AJJ, Honig WMM, Van der Heyden JAM, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45–58
Prell GD, Green JP (1986) Histamine as a neuroregulator. Annu Rev Neurosci 9:209–254
Roth RH, Tam S-Y, Ida Y, Yang J-X, Deutch AY (1988) Stress and the mesocorticolimbic dopamine systems. In: Kalivas PW, Nemeroff CB (eds) The mesocorticolimbic dopamine system. The New York Academy of Sciences, New York, pp 138–147
Sakai N, Onodera K, Maeyama K, Yanai K, Watanabe T (1991) Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell deficient Wv/Wv mice. Life Sci 48:2397–2404
Sakai N, Onodera K, Maeyama K, Yanai K, Watanabe T (1992) Effects of (S)-α-fluoromethylhistidine and metoprine on locomotor activity and brain histamine content in mice. Life Sci 51:397–495
Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS (1991) β-Endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology 104:51–56
Steele RGD, Torrie JH (1960) Principles and procedures of statistics. McGraw Hill, New York
Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 367:1–49
Author information
Authors and Affiliations
Additional information
Correspondence to A. E. Fleckenstein at the above address
Rights and permissions
About this article
Cite this article
Fleckenstein, A.E., Lookingland, K.J. & Moore, K.E. Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 347, 50–54 (1993). https://doi.org/10.1007/BF00168771
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168771